Stigma and quality of co-located care for HIV-positive people in addiction treatment in Ukraine: a cross-sectional study.
HIV
bias
co-located care
discrimination
injection drug use
quality of care
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
18
09
2019
accepted:
25
03
2020
entrez:
7
5
2020
pubmed:
7
5
2020
medline:
31
12
2020
Statut:
ppublish
Résumé
Co-located treatment for HIV and opioid use disorder has been shown to improve care outcomes for HIV-positive people who inject drugs (PWID) in Ukraine. However, patients continue to be stigmatized for both HIV and substance use. This study aimed to assess whether co-located care for HIV-positive PWID receiving opioid agonist treatment (OAT) services in Ukraine is associated with less stigma and better perceived quality of HIV services. This cross-sectional study enrolled 191 HIV-positive PWID who received OAT services at three healthcare facilities providing substance use treatment (OAT only) and at four facilities that provided co-located care (both OAT and HIV treatment) in six regions in Ukraine during July-September, 2017. Primary outcomes were HIV stigma (Berger scale), substance use stigma (Substance Abuse Stigma Scale) and intersectional stigma (both stigma forms above 75th percentile). Secondary outcome was quality of HIV care, a composite score based on a package of received services. Linear and ordinal regressions were used to assess the predictors of selected outcomes. Study participants were 75% male, mean age 40 ± 7 years; 47% received co-located care, and 10.5% had both high HIV and substance use stigma. Co-located care was neither associated with HIV nor substance use stigma but it was linked to better quality of HIV care (adjusted odds ratio: 4.13; 95% CI: 2.31, 7.54). HIV stigma was associated with suicide attempts (adjusted beta (aβ): 5.90; 95% CI: 2.05, 9.75), and substance use stigma was linked to poor mental health (aβ: -0.26; 95% CI: -0.44, -0.08) and lower likelihood of receipt of services from non-governmental organization (NGO; aβ: -6.40; 95% CI: -10.23, -2.57). One in ten people with HIV in this cohort who received OAT services experienced high levels of both HIV and substance use stigma, which was associated with poorer mental health and less NGO support. Co-located HIV and OAT services were linked to better perceived quality of HIV care, but did not seem to reduce stigma for this key population. Stigma interventions for PWID, possibly delivered involving NGOs, may be an approach to mitigate this challenge.
Identifiants
pubmed: 32372534
doi: 10.1002/jia2.25492
pmc: PMC7201176
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25492Subventions
Organisme : NIDA NIH HHS
ID : K99 DA041245
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA041245
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States
Informations de copyright
© 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.
Références
AIDS Care. 2017 Sep;29(9):1119-1128
pubmed: 28281354
Soc Sci Med. 2015 Apr;130:154-61
pubmed: 25703668
J Urban Health. 2017 Jun;94(3):319-329
pubmed: 28243868
Drug Alcohol Depend. 2014 Jan 1;134:106-114
pubmed: 24128379
PLoS One. 2015 Aug 25;10(8):e0136030
pubmed: 26305697
BMC Med. 2019 Feb 15;17(1):17
pubmed: 30764819
Soc Sci Med. 2019 Feb;223:73-76
pubmed: 30711781
AIDS Behav. 2016 Dec;20(12):2950-2960
pubmed: 27011378
Med Care. 1988 Jul;26(7):709-23
pubmed: 3393031
Int J Ment Health Addict. 2013 Feb 1;11(1):110-122
pubmed: 23956702
J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640
pubmed: 24242258
AIDS Behav. 2012 Nov;16(8):2181-91
pubmed: 22246517
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Int J Tuberc Lung Dis. 2018 Feb 1;22(2):197-205
pubmed: 29506617
AIDS Behav. 2016 Jan;20(1):85-97
pubmed: 26050155
AIDS Behav. 2012 Apr;16(3):711-6
pubmed: 21380495
J Assoc Nurses AIDS Care. 2009 May-Jun;20(3):161-8
pubmed: 19427593
Subst Use Misuse. 2010;45(1-2):47-57
pubmed: 20025438
Soc Sci Med. 2014 Jun;110:10-7
pubmed: 24704889
BMJ Open. 2016 Jul 13;6(7):e011453
pubmed: 27412106
Health Res Policy Syst. 2019 Feb 28;17(1):23
pubmed: 30819203
AIDS Care. 2017 May;29(5):559-563
pubmed: 27871198
Drug Alcohol Depend. 2013 May 1;129(3):180-209
pubmed: 23306095
AIDS Behav. 2017 Sep;21(9):2609-2617
pubmed: 28600603
Addict Sci Clin Pract. 2017 Oct 18;12(1):23
pubmed: 29041950
Health Policy Plan. 2013 Oct;28(7):681-91
pubmed: 23197431
PLoS One. 2019 Jan 24;14(1):e0210412
pubmed: 30677778
Res Nurs Health. 2001 Dec;24(6):518-29
pubmed: 11746080
J Consult Clin Psychol. 2012 Feb;80(1):43-53
pubmed: 22040285
BMC Public Health. 2018 Jul 27;18(1):919
pubmed: 30049270
Eur J Public Health. 2020 Feb 1;30(1):23-30
pubmed: 31270547
Subst Abuse. 2017 Mar 23;11:1178221816685087
pubmed: 28469424
Ann Behav Med. 2018 Aug 16;52(9):762-772
pubmed: 30124756